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The discovery that enhancers are regulated tran-
scription units, encoding eRNAs, has raised new
questions about the mechanisms of their activation.
Here, we report an unexpected molecular mecha-
nism that underlies ligand-dependent enhancer acti-
vation, based on DNA nicking to relieve torsional
stress from eRNA synthesis. Using dihydrotestoster-
one (DHT)-induced binding of androgen receptor
(AR) to prostate cancer cell enhancers as a model,
we show rapid recruitment, within minutes, of DNA
topoisomerase I (TOP1) to a large cohort of AR-regu-
lated enhancers. Furthermore, we show that the DNA
nicking activity of TOP1 is a prerequisite for robust
eRNA synthesis and enhancer activation and is
kinetically accompanied by the recruitment of ATR
and the MRN complex, followed by additional com-
ponents of DNA damage repair machinery to the
AR-regulated enhancers. Together, our studies
reveal a linkage between eRNA synthesis and
ligand-dependent TOP1-mediated nicking—a strat-
egy exerting quantitative effects on eRNA expression
in regulating AR-bound enhancer-dependent tran-
scriptional programs.INTRODUCTION
Research over the past few years, supported by data from GRO
sequencing (GRO-seq) analysis and the ENCODE project, has
revealed that most developmental and regulatory transcriptional
regulation programs are controlled by an extensive enhancer
network (Kim et al., 2010; Shlyueva et al., 2014), with each cell
type estimated to harbor 70,000–100,000 enhancers, located
upstream and downstream of coding target gene promoters
(Pennacchio et al., 2013). Enhancer signatures includemonome-
thylated H3K4 (H3K4me1) and H3K27-acetylated histones (Kim
et al., 2010; Li et al., 2013a; Wang et al., 2011). These enhancers
are usually characterized by a nucleosome-depleted core region
wheremany of the cooperating transcription factors bind (Ander-
sson et al., 2014; Hah et al., 2013; Kaikkonen et al., 2013; Laiet al., 2013; Lam et al., 2013; Li et al., 2013a; Melgar et al.,
2011; Melo et al., 2013; Mousavi et al., 2013). Most surprisingly,
enhancers are also transcription units, wherein their effect on
target coding genes correlates with the transcription of the
lncRNAs, referred to as eRNAs (Andersson et al., 2014; De Santa
et al., 2010; Hah et al., 2013; Kaikkonen et al., 2013; Kim et al.,
2010; Lai et al., 2013; Lam et al., 2013; Li et al., 2013a; Melgar
et al., 2011; Melo et al., 2013; Mousavi et al., 2013) adding a
new layer of regulation to the fundamental mechanisms underly-
ing enhancer action (Lam et al., 2014; Natoli and Andrau, 2012).
The current prevailing belief, based on chromosome capture
assays, where looping constraints are inferred from interaction
frequencies between a point of interest and distal loci of the
genome, is that the main mechanism by which enhancers affect
their target gene expression is through chromatin looping.
eRNA transcripts seem to be functionally important by contrib-
uting to the stabilization of juxtaposed enhancer-target gene
promoter loops to allow for optimal gene expression (Lai et al.,
2013; Li et al., 2013a). However, both eRNA synthesis and nucle-
osome depletion are potential sources of topological strain on
enhancers that can possibly hinder transcription. The move-
ment and rotation of RNA polymerase complex (RNAP) along
DNA template during the process of RNA synthesis (Liu and
Wang, 1987) can generate positive supercoils in front of the
advancing RNAP, and negative supercoils behind it (Darzacq
et al., 2007; Kouzine et al., 2013; Kouzine and Levens, 2007;
Liu and Wang, 1987). Because RNA polymerase is a powerful
torsional motor, it can alter DNA topology by creating DNA
supercoils, which can propagate and affect transcription elonga-
tion (Ma and Wang, 2014). Although negative supercoiling can
initially facilitate transcription initiation, either by helping RNAP
to form an open complex or by helping to recruit transcription
factors (Ma and Wang, 2014), it can subsequently lead to the
generation of R-loops resulting from hybridization of nascent
RNA to the DNA strand that is being transcribed, which, in
turn, can impede transcriptional elongation (El Hage et al.,
2010). Positive or overwound supercoiling can prevent transcrip-
tion initiation and greatly diminish mRNA synthesis (Ma and
Wang, 2014). Moreover, the very depletion of histones from the
core region of enhancers releases unconstrained negative
supercoils, which can impede transcription factor binding. One
mechanism that resolves the undesirable effects of excessive
supercoiling employs DNA topoisomerases, including topoisom-
erase I (TOP1). TOP1 can relax both negative and positiveCell 160, 367–380, January 29, 2015 ª2015 Elsevier Inc. 367
Figure 1. TOP1 Occupies AR Enhancers and Affects the Transcriptional Program of the Prostate Cancer Cell Line LNCaP
(A) Recruitment of AR and TOP1 to the KLK3 and KLK2 enhancers. The highest TOP1 binding is detected at 15 min DHT treatment. Data points showmean ± SD
(n = 3), *p < 0.05, **p < 0.01.
(B) The UCSC genome browser screenshot of the KLK3-KLK2 locus showing the occupancy of p-S5-RNA Pol II (Pol II), AR, and TOP1 (all tested with and without
DHT treatment).
(legend continued on next page)
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supercoils by transient single-strand breaks for the passage of
individual DNA strands through one another, followed by the
rejoining of the phosphodiester backbone of DNA (Pedersen
et al., 2012; Pommier et al., 2006).
Although TOP1 activity is well established in DNA replication,
its potential functionality in enhancer activation and transcrip-
tional initiation remains unclear. Most of the experiments hitherto
examining the role of TOP1 in transcription have been limited
to artificial promoter model systems, which, if anything, have
argued that TOP1 DNA nicking activity is not involved in
transcriptional activation in such in vitro systems (Kretzschmar
et al., 1993; Merino et al., 1993; Shykind et al., 1997).
However, the utilization of a nicking strategy for transcriptional
initiation and enhancer-regulated events would be in concert
with the elegant explication of themolecular mechanisms under-
lying the expression of bacteriophage T4 late genes, with the
participation of DNA-mounted activator of transcription, gp45
and RNAP-bound gp33. Here, a nick in the strands of the DNA
and the actions of an exonuclease are required, with the DNA
template single-strand nicks being essential for transcriptional
activation and the nicked-DNA gp45-loading site located up-
stream or downstream of its target site (Herendeen et al.,
1992). Also, in human cells, artificially generated nicks (but not
double-strand DNA breaks) have recently been found to be
associated with transcription (Davis and Maizels, 2014).
Together, these and other experiments in prokaryotes and
eukaryotes suggest an intriguing link between DNA nicking and
transcription, but the mechanism and the factors involved
remain largely unknown.
Here, we describe a molecular mechanism that operates at
functional androgen-regulated enhancers and identify DNA
topoisomerase I as a critical DNA-nicking enzyme involved in
the process of cell-specific, ligand-driven enhancer activation.
Recruitment of TOP1 to these AR-bound enhancers is of func-
tional consequence as knockdown of the enzyme in the prostate
cancer cells results in inhibition of DHT-regulated eRNA and
many coding gene transcriptional targets. Additionally, we pro-
vide evidence that recruitment of a significant repertoire of
DNA damage response machinery occurs on these functional
enhancers, potentially to prevent undesirable effects of persis-
tent DNA damage.
RESULTS
TOP1 Recruitment to AR-Regulated Enhancers Affects
eRNA and Coding Gene Expression
To further investigate the mechanism of enhancer activation in
ligand-regulated transcription, we employed an early prostate(C) GRO-seq analysis of the effect of TOP1 knockdown on nascent RNA levels s
DHT treatment) with the most affected AR enhancers at the top.
(D) Heatmap showing DHT-induced TOP1 sequencing tags density increase aro
(E) Box plot: siTOP1 reduced transcription at 80% of DHT-upregulated AR enh
(F) Box plot: the response to DHT of 368 DHT-upregulated genes was reduced a
(G) Knockdown of TOP1 affects the induction of both eRNA and mRNA. LNCaP c
stimulated with 100 nM DHT for 1 hr (eRNA) or 5 hr (mRNA) 48 hr posttransfectio
Data represent mean ± SD (n = 3), **p < 0.01.
(H) Recruitment of ATR to the KLK3 and KLK2 enhancers following DHT stimula
See also Figure S1 and Table S1.adenocarcinoma cell line, LNCaP, the growth of which is
androgen-dependent (Horoszewicz et al., 1980). The cell line is
exquisitely sensitive to androgen stimulation and arrests in
the G1 phase of the cell cycle upon steroid depletion, despite
the presence of peptide growth factors (Figure S1A). Regulation
of cyclin D expression and concomitant CDK4 activity repre-
sents one mechanism by which androgen impinges on the cell
cycle to govern proliferation (Knudsen et al., 1998).
To investigate whether TOP1 played a role in ligand-regulated
transcription, we undertook to examine the possible recruitment
of TOP1 to enhancers, finding that it was recruited to several AR
enhancers early in response to androgen (5a-dihydrotestoster-
one [DHT]) treatment in the ligand-dependent LNCaP prostate
cancer cell line (Figures 1A and S1B). These data prompted us
to study genome-wide localization of this protein by performing
chromatin immunoprecipitation coupled with next-generation
sequencing (ChIP-seq). Because exhaustive efforts to identify
a TOP1 antibody suitable for ChIP-seq proved unsuccessful,
we generated a stable LNCaP cell line with inducible biotinylated
TOP1 expression. We observed that TOP1 recruitment in
response to DHT, generated enriched regions of a range of sizes
(Figure 1B), as opposed to point sources, as found for factors
such as the androgen receptor, or broad sources, such as
observed for the H3K36me3 histone mark (Sims et al., 2014).
Consistent with the observation that enhancers represent regu-
lated transcription units, we noticed a hormone-dependent in-
crease in RNA Pol II (phospho-Ser5) occupancy predominately
at these enhancers (Figures 1B and S1C). As expected, we
also observed increased TOP1 occupancy over promoters and
gene bodies of the representative DHT-induced genes (e.g.,
KLK3 and KLK2), consistent with the possibility that TOP1 might
be involved in both enhancer activation and transcriptional elon-
gation events.
Preliminary analysis demonstrated that TOP1 binding overlap-
ped, in particular, with that of liganded androgen receptor at
enhancers (Figures 1B and S1C). Genome-wide analysis re-
vealed 6,545 putative ‘‘AR-bound enhancer’’ sites based on
the criterion of an AR-bound locus marked with H3K4me1 and
H3K27Ac and more than 1 kb away (in either direction) from
the promoter of annotated genes of which 96% bound TOP1,
with 3,921 (60%) exhibiting a DHT-stimulated increase in TOP1
binding (Figure S1D).
To assess eRNAs induced by DHT, we took advantage of
technological advances that permit mapping of the position,
amount, and orientation of transcriptionally engaged RNA
polymerase II on a genome-wide scale (Core et al., 2008).
GRO-seq analysis (Core et al., 2008) of serum-starved LNCaP
cells treated for 1 hr with DHT identified 644 putative ARhown as a heatmap for 579 enhancers (out of 644, which were upregulated by
und 644 AR-enhancer binding sites (centered on AR).
ancers. *p% 2.2 3 1016 (Wilcoxon test).
fter TOP1 knockdown by siRNA.
ells, hormone-starved for 1 day and transfected with the indicated siRNA, were
n. qRT-PCR was performed with SYBR Green using reverse-transcribed RNA.
tion of starved cells. Data represent mean ± SD (n = 3). **p < 0.01.
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enhancers with significantly upregulated eRNAs (Figure 1C),
which is the best mark of activated enhancers (Hsieh et al.,
2014; Li et al., 2013a), among which 477 (74%) were noted to
have increased TOP1 occupancy in response to ligand at
30 min (Figure 1D), and virtually all appear to exhibit DHT-
increased TOP1 binding at 15 min (Figure S5C). Because
TOP1 has been shown to affect the transcriptional activity of
RNA Pol II (Kretzschmar et al., 1993), we decided to investigate
whether knockdown of TOP1 would alter eRNA synthesis from
the androgen-regulated enhancers. Knockdown of endogenous
TOP1 by small interfering RNA (siRNA) revealed that eRNA in-
ductionwas reduced in at least 79% (507 of 644) of AR-regulated
enhancers (Figures 1C and 1E), accompanied by a decrease in
the induction of 368 coding target genes in the experiment
shown (Figure 1F), with similar results in repeat experiments.
Ninety-two percent of DHT-induced eRNAs were upregulated
more than 2-fold, with fold change average of 7.6 times. Analysis
of 100 randomly selected housekeeping genes not regulated by
DHT in our GRO-seq experiments confirmed that the specific
siRNAs used for this study had no effect on their expression (Ta-
ble S1).
To validate all major mechanistic points in this study, we chose
four enhancers gene pairs. Three of these enhancers (KLK3E,
KLK2E, and TMPRSS2E) are validated by previous studies
(Andreu-Vieyra et al., 2011; Clinckemalie et al., 2013; Hsieh
et al., 2014). The fourth one, NDRG1E, meets the criteria of
others. It is an AR-bound element located not too far away from
the NDRG1 gene TSS (29 kb), it is H3K4me1+, H3K27Ac+,
and following hormone stimulation the transcription unit pro-
duces DHT-dependent, bidirectional eRNA, making it a strong
candidate. Using these enhancer sites,we found that recruitment
of the nuclear receptor coactivators (p300 and SRC-1) at AR en-
hancers was diminished after siTOP1 (Figure S1E). Thus, TOP1
knockdown attenuated the induction of eRNA (1 hr DHT treat-
ment) and the production of mRNA of the corresponding target
genes5hr after ligand addition (Figures 1GandS1F). Importantly,
the fold induction (with orwithout DHT)was similar between inde-
pendent experiments in which eRNA levels were measured.
Surprisingly, we noted that ATR (Ataxia telangiectasia and
Rad3-related), a protein involved in DNA damage repair, was re-
cruited to AR-regulated enhancers at15 min following addition
of ligand (Figures 1H and S1G). Together, these data identify
TOP1-bound genomic regions that bear enhancer marks and
produce eRNA in a DHT-dependent manner. Knockdown of
TOP1 reduces production of eRNA and coding gene RNA for
most of these AR-regulated target genes.Figure 2. NKX3.1 and TOP1 Co-Occupy a Subset of AR Enhancers and
(A) The UCSC genome browser screenshot displaying a direct overlap between A
with increased (after DHT) TOP1-binding (except regions present in the backgro
(B) Knockdown of NKX3.1 prevents TOP1 from binding at AR-regulated enhance
5 min. Chromatin immunoprecipitation was performed with an antibody against
(C) Knockdown of NKX3.1 by siRNA affects the induced transcription of 69% o
(D) Heatmap of AR enhancers sorted from most-to-least affected by siNKX3.1.
(E) siNKX3.1 reduces induced transcription of 273 genes in this experiment dete
(F) The UCSC genome browser screenshot showing the KLK3-KLK2 locus. Knoc
(G) Knockdown of either TOP1 or NKX3.1 affects induction of the same 351 eRN
See also Figure S2 and Table S1.NKX3.1 and TOP1 Co-Occupy Enhancer Binding Sites
and Regulate the AR Transcription Program
NKX3.1 is an androgen-regulated transcription factor (Bhatia-
Gaur et al., 1999), which is a highly selective and specific marker
of metastatic prostatic adenocarcinoma (Gurel et al., 2010).
NKX3.1 has been found to interact with TOP1 to enhance forma-
tion of the TOP1-DNA complex and increase TOP1 nicking of
DNA (Bowen et al., 2007). In fact, TOP1 activity in prostates of
Nkx3.1 +/ and Nkx3.1/ mice is reduced compared with wild-
type mice, but not in other organs that do not express Nkx3.1
(Bowen et al., 2007). Overlap of the reported NKX3.1 ChIP-seq
data set (Tan et al., 2012) with that of AR and TOP1 revealed
that NKX3.1 occupancy was highest at AR enhancers, with
NKX3.1 binding sites located over regions with increased
TOP1 binding (Figures 2A and S2A). We observed that AR and
TOP1 started to be recruited to AR enhancers within a few
minutes after DHT stimulation. Interestingly, siRNA-mediated
knockdown of cellular NKX3.1 inhibited recruitment of TOP1 at
enhancers of DHT-regulated genes at 5 min following DHT stim-
ulation (Figure 2B), in line with the previous data suggesting that
NKX3.1 is needed for the formation of the TOP1-DNA cleavage
complex (Bowen et al., 2007). We observed that, following
NKX3.1 knockdown in LNCaP cells, the DHT-dependent upregu-
lation of 70% enhancer eRNAs was significantly reduced (Fig-
ures 2C, 2D and S2C). We also noted significant reduction in the
expression levels of 273 DHT-upregulated genes (Figure 2E),
exemplified for two representative genes (Figure 2F). Addition-
ally, knockdown of TOP1 andNKX3.1 reduced DHT upregulation
of eRNA at the same 351 AR enhancers in these experiments
(Figure 2G), apparently without affecting AR recruitment to the
enhancer-binding sites (Figure S2E). Together, these experi-
ments demonstrate that NKX3.1 and TOP1 binding occurs at a
subset of DHT-regulated enhancers, and the knockdown of
either diminishes transcription in response to ligand.
Catalytic Activity of TOP1 Is Required for DNA Nicking
and Enhancer Activation
Based on its mechanism of action as a DNA nickase, by which
TOP1 forms a covalent intermediate with DNA and possesses
intrinsic DNA ligase activity (Pommier et al., 1998; Champoux,
2001), it would be difficult to detect any such transient nick by
available methods. Indeed, despite extensive attempts to detect
such a nick in enhancers by primer extension approaches, only a
few examples could be clearly visualized. Thus, using this
approach to investigate whether AR-regulated enhancers might
be the sites of DNA scission by the activated TOP1, we chose theCo-Regulate the Enhancer Program
R, NKX3.1, and TOP1 binding at enhancers of KLK3 and KLK2 genes. Regions
und control) are underlined.
rs; siCTL-, siNKX3.1-, and siTOP1-treated cells were stimulated with DHT for
TOP1. Data represent mean ± SD (n = 3). **p < 0.01.
f the regulated eRNAs. *p% 2.2 3 1016 (Wilcoxon test).
rmined by GRO-seq.
kdown of TOP1 or NKX3.1 by siRNA reduces eRNA and genic RNA induction.
As in the same experiment, as measured by GRO-seq.
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Figure 3. TOP1 Recruits to AR-Regulated Enhancers and Nicks the DNA
(A) UCSC browser screenshot displaying the KLK3 enhancer. Arrows indicate the PRO-caps representing (putative) eRNA TSS that flank the NKX3.1 peak.
(B) eRNA readout assay showing that Tyr723 of TOP1 is required for eRNA induction. LNCaP cells were hormone-starved for 24 hr, transfected with siRNA to
knock down TOP1, and then electroporated with empty expression vector (Veh), wild-type TOP1 (WT), or the Y723F-TOP1 mutant (Mut) before treatment with
either ethanol or DHT for 1 hr. eRNA for KLK2, KLK3, and TMPRSS2 gene enhancers was quantified by RT-PCR. TOP1 mRNA and protein levels are also shown.
qPCR data show mean ± SD (n = 3). **p < 0.01.
(C) Knockdown of endogenous TOP1 affects nick/break formation as measured by incorporation of biotin 11-dUTP at selected AR enhancers after 10 min DHT
treatment. Data represent mean ± SD (n = 3). **p < 0.01.
See also Figure S3 and Table S2.KLK3 enhancer as a model. We examined a region overlapped
by the AR and NKX3.1 peaks and flanked by two ‘‘precision
nuclear run-on transcription initiation sites’’ (PRO-caps), which
mark the transcription initiation sites at high resolution (Kwak
et al., 2013), noting that PRO-cap sites could be located on
AR-regulated enhancers following hormone stimulation (Fig-
ure 3A, Table S2). Primer extension analysis of both DNA strands
with [g32P]-ATP-labeled oligonucleotides yielded several termi-
nation products consistent with a series of closely spaced
DNA nicks; the strongest band that became accentuated in
response to DHT was seen on the lower strand, in support of
the notion that it may be one of the major TOP1 binding/scission372 Cell 160, 367–380, January 29, 2015 ª2015 Elsevier Inc.sites (Figure S3B). Moreover, detailed PRO-cap analysis to
locate the precise start sites revealed that the RNA cap sites
located on average 134 bp away from the center of the AR
peak (Figure S3C) are occupied by TOP1 (Figure S3D) and, as
shown in GRO-seq experiments, these transcripts continue to
the end of eRNA-encoding sequence; however, for the majority
(75th percentile) of these transcripts, the GRO-seq signal starts
to fade away after 1,000 bp from the TSS/cap site.
As another approach to infer the possibility of TOP1 DNA nick-
ase actions in activation of AR-dependent enhancer, we sought
to mutate TOP1. TOP1 enzymatic activity depends on Tyr723
to relax superhelical DNA (Madden and Champoux, 1992).
Specifically, Tyr723 of TOP1 initiates the nucleophilic attack on
the backbone scissile phosphate resulting in nicked DNA and a
phosphodiester link between the tyrosine and 30 phosphate
(Champoux, 2001; Pommier et al., 2010). Subsequently, the
covalent intermediate is religated with concomitant release of
Tyr723 from the DNA (Champoux, 2001; Stewart et al., 1998).
We therefore tested whether the Y723F TOP1 mutant could
rescue the defect caused by TOP1 knockdown. For this pur-
pose, endogenous TOP1 was knocked down with specific
siRNA, and either the wild-type or the Y723F TOP1 mutant was
then expressed in LNCaP cells. Analysis of the enhancer RNA
after 1 hr DHT treatment revealed that the wild-type TOP1 largely
reinstated eRNA induction, whereas the catalytically inactive
mutant failed to do so (Figure 3B). The incomplete rescue with
the wild-type construct most likely reflected the fact that not all
cells could be efficiently electroporated with the DNA expression
vectors, probably because LNCaPs are notoriously difficult to
transfect with conventional cationic liposome reagents. Interest-
ingly, wild-type TOP1 relaxes supercoiled DNA only in the pres-
ence of NKX3.1, whereas the active site mutant does not at all
(Bowen et al., 2007), consistent with the presence of TOP1 on
AR-bound enhancers. These findings are of particular interest
based on previous in vitro transcription system analyses. TOP1
has been shown to be essential for transcriptional activation in
a system containing RNA polymerase II and other cofactors
(Kretzschmar et al., 1993; Merino et al., 1993; Shykind et al.,
1997), but, in these artificial in vitro transcription systems, the
Y723F mutant did not block the transcriptional activity of the
complex at promoters. Therefore, in this context, TOP1 was pro-
posed tomodulate transcription by changing the conformation of
DNAat thepromoter or via interactionswith TBP/TFIID (Kretzsch-
mar et al., 1993; Merino et al., 1993; Shykind et al., 1997). In
contrast, on AR-regulated enhancers, the nicking activity of
TOP1appears tobe required for its effectsoneRNA transcription.
Incorporation of labeled nucleotide by terminal deoxynucleo-
tidyl transferase (TdT) has been considered to label both DNA
nicks and double-stranded DNA (dsDNA) breaks (Gavrieli
et al., 1992); hence, we also employed this assay on specific
enhancer sites to assess incorporation of biotin 11-dUTP in
response to DHT. Therefore, we fixed the cells with Streck Cell
Preservative (Ju et al., 2006), a formulation shown not to cause
DNA breaks during the fixation process. Biotin 11-dUTP incor-
poration with TdT was observed at 10 min following addition of
DHT hormone at the several enhancers tested, and this was
strikingly reduced after TOP1 knockdown (Figure 3C). Together,
these data suggested that TOP1 recruitment to enhancers co-
occupied by AR and NKX3.1 occurred at regions proximal to
transcription initiation sites and caused single-stranded DNA
(ssDNA) nicks, although the possibility of a dsDNA break cannot
be ruled out, especially as an unligated nick can be converted to
a DSB for subsequent processing by the DSB repair pathway
(Davis and Maizels, 2014).
Involvement of MRE11 in the Regulation
of the AR Program
The MRN complex, composed of the meiotic recombination 11
(MRE11), RAD50, and Nijmegen breakage syndrome 1 (NBS1),
is central to the DNA damage response (DDR) pathway that isinitiated upon recognition of the DNA breaks by sensor proteins
(Stracker and Petrini, 2011). MRE11 regulates DNA repair by
recruitment of DNA-repair proteins that load onto the chromatin
at the site of the break (Price and D’Andrea, 2013).
Recent evidence shows that cleavage of the covalent 30 phos-
photyrosyl-DNA bonds that join TOP1 to the DNA backbone by
MRE11 generates a product carrying a 30-phosphate end that
MRE11-RAD50 can resect in an ATP-regulated reaction, pro-
ducing a 30-hydroxyl that can prime repair synthesis (Hamilton
and Maizels, 2010; Sacho and Maizels, 2011). Interestingly,
the p300 transcriptional coactivator physically interacts with all
three members of the MRN complex (Jung et al., 2005).
Based on these considerations and the results in Figure 3, we
investigated whether MRE11 was present at AR-regulated
enhancers. Kinetic ChIP experiments using a specific antibody
(Figures 4A and S4A) revealed that MRE11 recruitment at
enhancer-binding sites peaked at 15 min of DHT treatment. On
performing ChIP-seq, we identified 19,886 loci in the (–) hormone
control and 30,636 loci in the cells treated with DHT for 15 min,
observing that MRE11 sequencing tag density at enhancers
increased with DHT treatment (Figures 4B, 4C, and S4B). We
also observed similar recruitment of the RAD50 component
of the MRN complex (Figure S4C). Genome-wide analysis
showed indistinguishable alterations in the number of tags over
promoters of these genes in response to DHT treatment,
although a small increase in MRE11 occupancy at promoters
of select DHT-regulated genes (e.g., KLK3, KLK2, NDRG1, and
TMPRSS2) could be detected by ChIP-qPCR after DHT treat-
ment (data not shown). GRO-seq analysis of nascent transcrip-
tion revealed that induction of 89% of detectible enhancer
eRNAs induced by DHT were inhibited by MRE11 knockdown
(Figures 4D and 4E). In addition, expression of 510 induced
coding genes was reduced (Figure 4F). Knockdown of RAD50
caused a similar effect on eRNA and mRNA expression levels
(Figure S4D). Given the role of ATR in sensing single-strand
DNA breaks, we also investigated the potential functional role
of ATR following DHT. We found that ATR is rapidly recruited,
by 15 min, to AR-bound enhancers after DHT (Figure 1H). This
is of functional significance, because knockdown of either
MRE11 or TOP1 caused dramatic decrease in ATR recruitment
to enhancers (Figure 4G) and a reduction of DHT-induced
enhancer and gene transcription (Figure 4H).
Recruitment of Components of DDR
to AR-Regulated Enhancers
Indeed, a mechanism that could be involved in the repair of sin-
gle-strand nick would be the base excision repair pathway
(BER), to process nicks that evaded TOP1 ligase activity. There-
fore, we investigated whether factors involved in this or other
DNA damage repair pathways might also be recruited to AR-
regulated enhancers. We performed kinetic ChIP experiments
using antibodies against phospho-ATM (Ataxia telangiectasia
mutated), Ku80 (part of the Ku heterodimer that binds to dou-
ble-strand DNA break ends), Exonuclease 1 (EXO1), the Bloom
syndrome DNA helicase (BLM), and DNA ligase IV (LIGIV).
Additionally, we used antibodies to proteins involved in the
base excision repair pathway, including XRCC1 (X-ray repair
cross-complementing protein 1), DNA polymerases b and ε,Cell 160, 367–380, January 29, 2015 ª2015 Elsevier Inc. 373
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and Ligase I, observing an orderly and reproducible kinetics of
recruitment after hormone treatment at enhancers including
KLK3, KLK2, TMPRSS2, and NDRG1 (Figures 5 and S5A), as
well on other DHT-upregulated enhancers identified by the
GRO-seq (Figure S5B). Although TOP1 and ATRwere essentially
recruited simultaneously at enhancers at 15 min, XRCC1 was
recruited between 15 and 30min, consistent with the recruitment
of base excision repair pathway machinery that could process
any unligated nicks. Interestingly, DNA ligase IV showed
maximum occupancy after 30 min, whereas pATM (p-S1983),
Ku80, EXO1, BLM, and DNA ligase I were maximally recruited
to enhancers 60 min post DHT treatment (Figures 5 and
S5A), indicating recruitment of multiple DNA-repair factors that
have been conventionally considered to function in DNA damage
repair (Nimonkar et al., 2011). The sequence of events would be
consistent with resolving any unligated DHT/TOP1-induced
ssDNA nicks; the DDRmachinery primarily recruited as a ‘‘safety
net’’ against any DNA breaks that are not sealed by TOP1. From
our data, the machineries of transcription and DNA damage
repair seem to be intrinsically linked.
DISCUSSION
Regulated gene expression has been a subject of intense inves-
tigation over the past few decades, yet the precise mechanisms
by which enhancers orchestrate tissue-specific programs with
such an astonishing precision remain unclear. In particular, the
finding that enhancers are also regulated transcription units,
encoding eRNAs, has added to the mystery and raised new
questions about how the subsequent topological strain on
enhancers is handled. Both eRNA synthesis and nucleosome
depletion at enhancers are potential sources of topological
strain. Advancing RNA polymerase can generate both positive
and negative supercoils. The amount of supercoiling is poten-
tially enormous given that a positive and a negative supercoil is
generated for every 10 bp transcribed and that the length of an
eRNA transcript is typically 1–2 kbp in length. Indeed, it has
been estimated that approximately seven supercoils may be
generated by the transcribing polymerase per second, and that
these supercoils can propagate >1 kbp from the transcription
start site (Kouzine et al., 2013). At the same time, the depletion
of histones from enhancers releases unconstrained negative
supercoils, which, in principle, can parse to a change in DNA
twist or unwinding to facilitate transcription and/or to a change
in writhe that impedes transcription factor binding. To relieve
torsional stress, it is tempting to predict that cells might employFigure 4. MRE11 Regulates the AR Transcription Program
(A) Recruitment of MRE11 to the selected DHT-regulated AR enhancers. Data po
(B) MRE11 binding (sequencing tags density) increases over AR enhancers in a
(C) Distribution of MRE11 and AR binding (sequencing tag density) centered ove
(D) MRE11 knockdown reduces eRNA expression levels of 89% of DHT-upregul
(E) Heatmap for AR enhancers sorted from the most downregulated by siMRE11
(F) Boxplot showing 510 genes, where DHT-induced upregulation of transcriptio
(G) Knockdown of eitherMRE11 or TOP1 affects recruitment of ATR at enhancers
stimulation. Data show mean ± SD (n = 3). *p < 0.05, **p < 0.01.
(H) siATR affects induction of eRNA (1 hr DHT) and mRNA (5 hr DHT treatment) of
See also Figure S4 and Table S1.actions of DNA topoisomerases, including topoisomerase I as an
integral component of regulated enhancer transcription.
Here, we have elucidated the operation of just such a mecha-
nism in prostate cell-specific enhancer activation by androgen
receptor, using the LNCaP cancer cell line as amodel. In a sense
analogous to the role of TOP1 at origins of replication (Simmons
et al., 1998; Tsao et al., 1993), we show here that this DNA nick-
ase is rapidly recruited to a large cohort of AR/NKX3.1-occupied
enhancers to putatively activate the enhancers and relieve
torsional stress due to ongoing transcription (Figure 6). Our
results are consistent with observations that, in yeast cells,
Top1/Top2 play a role in the activation of genes characterized
by high transcriptional plasticity (Pedersen et al., 2012). How-
ever, the beneficial effects of TOP1 have to be weighed against
the negative effects of retention of TOP1 as an obstacle to further
transcription and the deleterious effects of a single-strand nick
if it is not quickly sealed by TOP1 itself, or repaired by the base
excision pathway. Unrepaired nicks could lead to the formation
of DNA double-strand breaks (DSB) as, for example, when a
replication fork runs into and collapses at a nick (Kuzminov,
2001; Wimberly et al., 2013). It has also been suggested that a
codirectional collision between the replisome and backtracked
RNA polymerase transcription elongation complexes leads to
DNA double-strand breaks (Dutta et al., 2011). Thus, one impor-
tant role for the MRN complex and other components of the
DDR machinery that we observe recruited to the TOP1-bound
enhancers might be for the removal of any ‘‘stalled’’ TOP1
from the DNA substrate, as well as repair of any possible DNA
breaks that might occur despite TOP1 or the BER actions (Ham-
ilton and Maizels, 2010; Sacho and Maizels, 2011; Davis and
Maizels, 2014).
TOP1 activity is likely to be modulated by factors other than
NKX3.1, suggesting that the mechanism we describe here may
not be restricted to prostate cells. In this regard, it has been
shown that the catalytic activity of TOP1 is stimulated by large
T antigen during unwinding of the SV40 origin (Simmons et al.,
1998) and overexpression of the antigen rendered LNCaP cells
androgen-independent for cell-cycle progression (Knudsen
et al., 1998). This raises the possibility that activation of TOP1
catalytic activity may, in part, trigger a switch to androgen inde-
pendence. The Werner syndrome helicase, WRN, has also been
found to enhance the ability of TOP1 to relax negatively super-
coiled DNA and specifically stimulate the religation step of the
relaxation reaction (Laine et al., 2003). It is therefore not unlikely
that there exist other, yet undiscovered, activators of TOP1 cat-
alytic activity to regulate eRNA synthesis and gene expressionints show mean ± SD (n = 3). *p < 0.05, **p < 0.01.
DHT-dependent manner (KLK3 and KLK2 genes shown).
r AR-enhancer binding sites with DHT-induced eRNA.
ated eRNAs. *p% 2.2 3 1016 (Wilcoxon test).
at the top to the least, at the bottom.
n (determined by GRO-seq) was reduced by MRE11 knockdown.
following hormone stimulation of the starved cells, measured after 15 min DHT
the corresponding gene. Data are the mean ± SD (n = 3). *p < 0.05, **p < 0.01.
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Figure 5. Canonical DNA Damage/Repair Machinery Components Recruit to AR-Regulated Enhancers
Kinetic recruitment of factors implicated in the DNA damage response (DDR) to AR enhancers. All kinetic ChIP experiments were performed at least twice with
cells of similar passage number to ensure data reproducibility. Data shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01. See also Figure S5.programs. Alternatively, there may be other DNA nickases that
initiate enhancer activation in tissues other than prostate, in
signal-dependent manner, and that the activities of those
nickases are modulated by enhancer-bound factors.376 Cell 160, 367–380, January 29, 2015 ª2015 Elsevier Inc.Although the finding that ligand-dependent enhancer activa-
tion strategy would involve a DNA nick may seem counterintui-
tive in terms of cellular integrity, it is noteworthy that cellular
integrity is threatened daily by endogenous and extracellular
Figure 6. A Model for TOP1-Mediated Acti-
vation of the AR Enhancer
Following androgen stimulation, AR and DNA
topoisomerase I recruit to the enhancer region,
premarked by the NKX3.1 pioneer transcription
factor. NKX3.1 to TOP1 stimulates enzymatic ac-
tivity of the topoisomerase, resulting in nicking of
DNA on a single strand, followed by recruitment of
ATR, XRCC1, and the MRN complex components
(MRE11/RAD50). After dismissal of TOP1, ATR,
and the MRN, additional components of DNA-
repair machinery recruit to the activated enhancer.
The thin blue line indicates the presence of low
levels of residual eRNA, not totally eliminated by
hormone starvation, whereas the thick blue line
represents induced bidirectional eRNA produced
by the transcription unit.agents that lead to the formation of single- and double-strand
DNA breaks. For instance, the estimated number of single-
strand breaks and spontaneous base losses in nuclear DNA
together with other types of spontaneous damage may reach
105 lesions per cell per day (Hoeijmakers, 2009), yet the cells
are programmed to survive. To maintain genomic integrity, cells
constantly engage the DNA-repair machinery. As such, the us-
age of a programmed DNA nicking/repair strategy in regulated
transcription to relieve torsional stress and activate transcription
in this case, while apparently surprising, is in keeping with
growing evidence that components of DNA damage machinery
do participate in transcriptional regulation. For instance, Rein-
berg and colleagues demonstrated that human RNA polymerase
II complex contains components with roles in DNA repair,
including Ku70, Ku80, and DNA Pol ε (Maldonado et al., 1996),
and Kung and colleagues (Mayeur et al., 2005) have identified
heterotrimeric DNA-dependent protein kinase subunits: Ku70,
Ku80, and DNA-PKcs, as well as poly(ADP-ribose) polymerase
as proteins associated with the C-terminal domain of AR and
demonstrated that, in LNCaP cells, Ku70 and Ku80, recruited
to the KLK3 promoter and enhancer in a hormone-dependent
manner. Interestingly, Ku70 and Ku80 can function outside of
the Ku heterodimer that loads on double-strand DNA breaks.
Hasty and colleagues have shown that Ku80 deletion impairs
the base excision pathway (BER) at the initial lesion recogni-
tion/strand scission step, arguing that free Ku70 and free
Ku80, but not the Ku heterodimers, associate with apurinic/apyr-
imidinic (AP) sites that BER corrects (Li et al., 2013b; Choi et al.,
2014). Moreover, Mo and Dynan showed that, in normally
growing human cells, Ku80 associated with RNA polymerase II
elongation sites. This association occurred independently ofCell 160, 367–380the DNA-dependent protein kinase cata-
lytic subunit and was highly selective. In
addition, there was no detectable associ-
ation with the initiating isoform of RNAPII
or with the general transcription initiation
factors. The authors concluded that as-
sociation of Ku80 with transcription sites
is important for maintenance of global
transcription levels, because functionaldisruption of a discrete C-terminal domain in the Ku80 subunit in-
hibited transcription in vitro and in vivo (Mo and Dynan, 2002).
Importantly, LigIV, like Ku80, is commonly associated with the
NHEJ pathway, but its active site has been found to be highly
permissive and capable of ligating atypical DNA substrates,
including nicks with gaps (Gu et al., 2007). Interestingly, in the
absence of RNase H2, the suppression of mutations arising
from misinsertion of ribonucleoside monophosphates (rNMP)
during DNA replication involves Top1-mediated cleavage at an
rNMP, followed by unwiding of DNA by Srs2 and digestion by
Exo1 (Potenski et al., 2014). Also, earlier studies showed that
TOP1 enhanced TFIID-TFIIA complex assembly during activa-
tion of transcription; however, in these biochemical studies, the
catalytic activity of TOP1 was not essential to activate transcrip-
tion from promoters. It is also interesting to note that the AR itself
has been shown to transcriptionally regulate a network of DNA-
repair genes, including those implicated in DNA damage sensing
(MRE11, NBN, and ATR), nonhomologous end joining (XRCC4
and XRCC5), homologous recombination (RAD54B and
RAD51C), mismatch repair (MSH2 and MSH6), base excision
repair (PARP1 and LIG3), and the Fanconi pathway (FANC1,
FANCC, and USP1) (Polkinghorn et al., 2013). Moreover, p53 it-
self binds enhancers and regulates eRNA synthesis for transcrip-
tion enhancement of neighboring genes (Melo et al., 2013).
Together, the recruitment of DNA damage response machin-
ery in specific transcriptional regulatory events is an emerging
theme, from the regulation of pluripotency in embryonic stem
cells by the trimeric XPC-nucleotide excision repair complex
(Fong et al., 2011) to the regulation of human RARb2 gene via
XPG induced DNA breaks at the promoter region (Le May
et al., 2012). Moreover, experiments with yeast have revealed, January 29, 2015 ª2015 Elsevier Inc. 377
that the Rad1XPF/Rad10ERCC1, Mms4Emi1 orthologs can catalyze
the endonucleolytic cleavage of DNA immediately upstream
from the Top1-DNA adduct (Pommier et al., 2010). Indeed,
permissive chromatin architecture seems to be a crucial require-
ment for transcription initiation events (Fong et al., 2013).
Although these events are quite distinct from the TOP1-depen-
dent regulatory events described in the present manuscript,
they do suggest a common usage of the DNA damage repair
machinery to regulate gene transcription.
EXPERIMENTAL PROCEDURES
Cell Culture
LNCaP cells were purchased from ATCC and maintained in RPMI-1640
medium (Life Technologies) supplemented with 10% fetal bovine serum
(Omega Scientific), 2 mM L-glutamine, and penicillin/streptomycin. For kinetic
ChIP experiments, cells were starved in phenol-free DMEM (Lonza) supple-
mented with 5% charcoal:dextran stripped fetal bovine serum (Omega Scien-
tific) for 72 hr. Cells were synchronized with 2.5 mM a-amanitin (Sigma) for 2 hr,
washed twice with PBS, and released. A total of 100 nM 5a-Dihydrotestoster-
one (DHT, Sigma) was added to the starvation media to stimulate the cells.
Small Interfering RNA
siRNA-mediated knockdown was achieved by transfecting cells with Lipo-
fectamine 2000 and specific siRNAs. The following siRNAs were used for
this study: AllStars Neg. Control siRNA (1027281) was from QIAGEN. Human
ON-TARGETplus SMARTpool siRNAs against TOP1 (L-005278-00-0020),
MRE11 (L-009271-00-0020), and RAD50 (L-005232-00-0005) were purchased
from Dharmacon. Single interfering RNAs targeting AR (SASI_Hs01_
00224483, SASI_Hs01_00224484), TOP1 (SASI_Hs02_00335354, SASI_
Hs01_00047440), ATR (SASI_Hs01_00176270, SASI_Hs01_00176271), and
NKX3.1 (SASI_Hs02_00341026, SASI_Hs01_00018365) were obtained from
Sigma. Multiple siRNAs were used during the course of the study to confirm
data reproducibility.
For transfection, LNCaP cells were seeded on dishes in RPMI-1640 supple-
mented with 10% FBS and allowed to attach overnight. The following day,
the cells were washed twice with PBS and fed with phenol-free DMEM supple-
mented with 5% charcoal:dextran FBS. One day later, the cells were
transfected using Lipofectamine 2000 and 20 pmol ml1 siRNA diluted in
Opti MEM reduced serum media without phenol red (Life Technologies). The
transfection media was removed after 16 hr incubation, and the cells were
washed twice with PBS. Fresh, phenol-free DMEM supplemented with 5%
charcoal:dextran FBS and penicillin/streptomycin was added to the dishes.
Cells were harvested 48–72 hr posttransfection. All siRNAs used in this study
were validated by vendors or by us and used only if providing >70% knock-
down efficiency. Relative quantities of gene expression level were normalized
to the GAPDH gene. The relative quantities of ChIP samples were normalized
by individual inputs, respectively.
ChIP-qPCR
Chromatin immunoprecipitation experiments were done as previously
described (Garcia-Bassets et al., 2007). All ChIPs and qPCRs were repeated
at least thrice and representative results were shown. p values were calculated
by using a two-tailed Student’s t test.
GRO-Seq and PRO-Cap
Global run-on sequencing (GRO-seq) was performed as detailed (Wang et al.,
2011), and precision nuclear run-on sequencing of transcription initiation
sites (PRO-cap) was performed as described (Kwak et al., 2013).
Antibodies
AR (N-20), TOP1 (H-300), ATR (N-19), RAD50 (H-300), XRCC1 (H-300), BLM
(H-300), DNA Ligase I (C-21), DNA Ligase IV (H-300), DNA POL b (C-21),
DNA POL ε 3/CHRAC17 (N-15), p300 (C-20), SRC-1 (M-341) were from
Santa Cruz Biotechnology. MRE11 (Ab397) and p-S1983-ATM (Ab2888)378 Cell 160, 367–380, January 29, 2015 ª2015 Elsevier Inc.were obtained from Abcam. Ku80 (A302-627A) and EXO1 (A302-639A)
were purchased from Bethyl Laboratories. See also Extended Experimental
Procedures.
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